Biograil

Description

Biograil develops proprietary BIONDD® technology for oral delivery of biologics, using it in preclinical pharmaceutical work to turn injectable pharmaceutical products into convenient oral capsules.

Biograil is located in the Copenhagen ecosystem.

Related

• PharmathenPharmathen develops and manufactures pharmaceutical dosage forms, APIs, and formulation technologies for branded and generic partners,…
• Arctic BioscienceArctic Bioscience develops and manufactures marine membrane lipid extracts for pharmaceutical and nutraceutical applications, including…
• EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
• OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…
• CamurusCamurus develops and commercializes long-acting pharmaceutical medicines using its proprietary FluidCrystal technology for treatment of…
• Particle AnalyticalParticle Analytical provides GMP-certified solid-state characterization services that perform solid form screening, method development and…
• APCAPC provides process development services and technology platforms that accelerate pharmaceutical and biologics development for pharma and…
• Nanoform Finland OyjNanoform Finland Oyj builds nanotechnology-enabled formulation and GMP manufacturing processes to improve bioavailability and drug loading…
• Ability PharmaceuticalsAbility Pharmaceuticals develops oral targeted anticancer compounds that induce selective autophagy-mediated cytotoxicity in cancer cells;…